US Bancorp’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208 | Sell |
184
-6,784
| -97% | -$7.67K | ﹤0.01% | 4068 |
|
|
2025
Q1 | $10.2K | Buy |
6,968
+6,229
| +843% | +$9.09K | ﹤0.01% | 3417 |
|
|
2024
Q4 | $1.57K | Sell |
739
-1,043
| -59% | -$2.22K | ﹤0.01% | 3892 |
|
|
2024
Q3 | $4.99K | Buy |
1,782
+212
| +14% | +$594 | ﹤0.01% | 3558 |
|
|
2024
Q2 | $3.66K | Sell |
1,570
-1,813
| -54% | -$4.22K | ﹤0.01% | 3581 |
|
|
2024
Q1 | $15.1K | Hold |
3,383
| – | – | ﹤0.01% | 3184 |
|
|
2023
Q4 | $10.9K | Buy |
3,383
+826
| +32% | +$2.65K | ﹤0.01% | 3295 |
|
|
2023
Q3 | $8.11K | Buy |
2,557
+859
| +51% | +$2.72K | ﹤0.01% | 3242 |
|
|
2023
Q2 | $8.44K | Buy |
1,698
+1,210
| +248% | +$6.01K | ﹤0.01% | 3294 |
|
|
2023
Q1 | $2.41K | Sell |
488
-2,842
| -85% | -$14K | ﹤0.01% | 3692 |
|
|
2022
Q4 | $20.9K | Sell |
3,330
-1,593
| -32% | -$10K | ﹤0.01% | 2963 |
|
|
2022
Q3 | $54K | Sell |
4,923
-551
| -10% | -$6.04K | ﹤0.01% | 2479 |
|
|
2022
Q2 | $63K | Buy |
5,474
+1,616
| +42% | +$18.6K | ﹤0.01% | 2455 |
|
|
2022
Q1 | $35K | Buy |
3,858
+1,010
| +35% | +$9.16K | ﹤0.01% | 2781 |
|
|
2021
Q4 | $42K | Buy |
2,848
+2,301
| +421% | +$33.9K | ﹤0.01% | 2725 |
|
|
2021
Q3 | $14K | Sell |
547
-9,863
| -95% | -$252K | ﹤0.01% | 3265 |
|
|
2021
Q2 | $271K | Buy |
10,410
+42
| +0.4% | +$1.09K | ﹤0.01% | 1844 |
|
|
2021
Q1 | $366K | Buy |
10,368
+10,071
| +3,391% | +$356K | ﹤0.01% | 1652 |
|
|
2020
Q4 | $7K | Buy |
297
+247
| +494% | +$5.82K | ﹤0.01% | 3269 |
|
|
2020
Q3 | $2K | Sell |
50
-23
| -32% | -$920 | ﹤0.01% | 3399 |
|
|
2020
Q2 | $3K | Buy |
73
+23
| +46% | +$945 | ﹤0.01% | 3340 |
|
|
2020
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 3454 |
|
|
2019
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 3482 |
|
|
2019
Q3 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 3470 |
|